ATE87661T1 - Antidiabetikaverbindungen. - Google Patents

Antidiabetikaverbindungen.

Info

Publication number
ATE87661T1
ATE87661T1 AT85304164T AT85304164T ATE87661T1 AT E87661 T1 ATE87661 T1 AT E87661T1 AT 85304164 T AT85304164 T AT 85304164T AT 85304164 T AT85304164 T AT 85304164T AT E87661 T1 ATE87661 T1 AT E87661T1
Authority
AT
Austria
Prior art keywords
diabetic compounds
compounds
diabetic
insulin
chem
Prior art date
Application number
AT85304164T
Other languages
English (en)
Inventor
Bruce Hill Frank
Allen Howard Pekar
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of ATE87661T1 publication Critical patent/ATE87661T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/26—Containing cys-cys disulfide bridge between nonadjacent cysteine residues

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT85304164T 1984-06-14 1985-06-12 Antidiabetikaverbindungen. ATE87661T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/620,782 US4569791A (en) 1984-06-14 1984-06-14 Anti-diabetic compounds
EP85304164A EP0171147B1 (de) 1984-06-14 1985-06-12 Antidiabetikaverbindungen

Publications (1)

Publication Number Publication Date
ATE87661T1 true ATE87661T1 (de) 1993-04-15

Family

ID=24487365

Family Applications (1)

Application Number Title Priority Date Filing Date
AT85304164T ATE87661T1 (de) 1984-06-14 1985-06-12 Antidiabetikaverbindungen.

Country Status (7)

Country Link
US (1) US4569791A (de)
EP (1) EP0171147B1 (de)
JP (1) JPS6117599A (de)
AT (1) ATE87661T1 (de)
CA (1) CA1243972A (de)
DE (1) DE3587226T2 (de)
DK (1) DK262685A (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63157498U (de) * 1987-03-31 1988-10-14
US4888414A (en) * 1987-04-09 1989-12-19 Board Of Regents, University Of Texas System Insulin-binding peptides and uses thereof
US4992417A (en) * 1987-07-17 1991-02-12 Mount Sinai School Of Medicine Superactive human insulin analogues
US4992418A (en) * 1987-07-17 1991-02-12 Mount Sinai School Of Medicine Superactive human insulin analogue-[10-Aspartic Acid-B]Human Insulin
US5208217A (en) * 1989-04-20 1993-05-04 Mount Sinai School Of Medicine Of The City University Of New York Hepatospecific insulin analogues
CZ342492A3 (en) * 1991-11-26 1993-06-16 Lilly Co Eli Derivatives of tri-arginine insulin, process of their preparation and a pharmaceutical composition in which said derivatives are comprised
US6001604A (en) * 1993-12-29 1999-12-14 Bio-Technology General Corp. Refolding of proinsulins without addition of reducing agents
US5631347A (en) * 1995-06-07 1997-05-20 Eli Lilly And Company Reducing gelation of a fatty acid-acylated protein
EP1265630B1 (de) 2000-03-24 2006-06-07 Genentech, Inc. Verwendung von insulin zur behandlung von knorpelkrankheiten

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3209184A1 (de) * 1982-03-13 1983-09-15 Hoechst Ag, 6230 Frankfurt Verfahren zur umwandlung von praeproinsulinanaloga zu insulinen

Also Published As

Publication number Publication date
JPS6117599A (ja) 1986-01-25
CA1243972A (en) 1988-11-01
DE3587226T2 (de) 1993-08-05
EP0171147B1 (de) 1993-03-31
US4569791A (en) 1986-02-11
EP0171147A2 (de) 1986-02-12
EP0171147A3 (en) 1989-01-18
DE3587226D1 (de) 1993-05-06
DK262685A (da) 1985-12-15
DK262685D0 (da) 1985-06-12

Similar Documents

Publication Publication Date Title
ATE86668T1 (de) Antidiabetikaverbindungen.
DK142985D0 (da) Redox-indikatorer
FI875059A (fi) Foereningar.
ES8801233A1 (es) Un procedimiento para la preparacion de acidos 3-hidroxifenoxialquilenheterociclilcarboxilicos.
DE3772015D1 (de) Chinolinverbindung.
ATE87662T1 (de) Antidiabetikaverbindungen.
ATE87661T1 (de) Antidiabetikaverbindungen.
NO872409L (no) Substituerte 4-benzylpiperazinyl-forbindelser.
FI874311A0 (fi) 7-/(meta-substituerade)fenylglysin/ -1-karba-1-detiakefalosporiner.
ES2001676A6 (es) Procedimiento para la preparacion de derivados propionamidinos
ES8504736A1 (es) Un procedimiento para la preparacion de compuestos de imidazolilpropanol opticamente activos
SU1005420A1 (ru) S-(5-Нитрофурфурил-2)-тиуроний бромид, обладающий антимикробной активностью
SU1319521A1 (ru) 5-(2,2,2-Трифтор-1-окси-1-трифторметилэтил)фурил-2-метилгидразонийбромид, проявляющий антимикробную и противовоспалительную активность
SU961332A1 (ru) [5-(2,2-Диметил-4,6-диоксо-1,3-диоксан-5-метенил)фурил-2]-(бензотиазолил-2) сульфид, проявляющий антимикробную активность
SU565494A1 (ru) ω-орто-хлоранилид α-изобутил-β-метилглутаровой кислоты или его натриевая соль, проявляющие противовоспалительную и анальгезирующую активность
SU1351063A1 (ru) Производные 2-тиазолзамещенного 5-нитрофурана, проявляющие антистафилококковую активность
SU997415A1 (ru) Гидразоны 1,3-диметил-6-гидразиноурацила, проявляющие анальгетическую активность
SU1202241A1 (ru) Натриевая соль 5-n-хлорбензилидентиазолидиндиона-2,4, обладающая противогрибковой активностью
SU754825A1 (ru) Бромистоводородная соль 6-оксо-7-окса-3,4-диазобицикло (3,3,0) октадиена-1,4, проявляющая противовоспалительную и антимикробную активность
SU860457A1 (ru) Гидробромид метилового эфира 4-карбэтокси-4-(бензимидазолил-2-меркаптоацетил)октановой кислоты, обладающий противовоспалительной активностью
SU997416A1 (ru) Диметил-5-нитрофурфурилсульфоний бромид, обладающий антимикробной активностью
SU1299112A1 (ru) 3-Метил-5-[(5-нитрофурфурил-2)-тио]-1,2,4-триазол или его гидрохлорид, обладающие антимикробной, анальгетической и противовоспалительной активностью
SU683200A1 (ru) α-пиридилгидразиды диарил- или диалкилгликолевой кислоты, проявляющие противовоспалительную активность
SU803375A1 (ru) Производные 5-м-нитробензилиденселеназолидиндиона-2,4, обладающие психотропной активностью
SU830761A1 (ru) Производные 5-арилидентиазолидиндиона-2,4, обладающие активностью в отношении фитофтороза томатов

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee